What Has Been the Progress and Growth of the Pertussis Vaccine Market in Recent Years?
The pertussis vaccine market has seen considerable growth due to a variety of factors.
• In recent times, the market size of the pertussis vaccine has experienced consistent growth. The market is expected to expand from a valuation of $5.5 billion in 2024 to $5.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.1%.
The increase witnessed during the historical period can be credited to factors such as disease prevalence, immunization initiatives, pediatric vaccinations, and regulatory authorizations.
How Does the Forecast Look for the Pertussis Vaccine Market?
The pertussis vaccine market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, a consistent increase in size is anticipated for the pertussis vaccine market. It's estimated that this market will expand to $6.62 billion by 2029, with a compound annual growth rate (CAGR) of 3.7%.
Various factors contributing to this expected growth in the forecast period include booster vaccinations, maternal immunization, healthcare worker immunization, and worldwide health initiatives. Looking ahead to the forecast period, main trends to watch out for include personalized immunization schedules, combination vaccines, equality initiatives for vaccines, and the application of digital health in immunization.
What Are The Leading Drivers Of Growth In The Pertussis Vaccine Market?
The upward trend in childbirth rates is propelling the expansion of the pertussis vaccine market. The process of birthing a child, referred to as childbirth, marks the end of a pregnancy and the start of a new life outside the uterus. The pertussis vaccine, which shields children from whooping cough and other dangerous diseases, is typically administered to children. As an illustration, the Centers for Disease Control and Prevention, a public health organization in the US, reported a 1% increase in registered births in the United States as of January 2023, bringing the total to 3,664,292 births. This upsurge in childbirth rates is fueling the pertussis vaccine market growth.
Pertussis Vaccine Market Driver: Boost in Geriatric Population Numbers Propels Pertussis Vaccine Market Growth
How Are The Segments Defined Within The Global Pertussis Vaccine Market?
The pertussis vaccine market covered in this report is segmented –
1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics
Subsegments:
1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP
2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine
Pre-Book The Pertussis Vaccine Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Pertussis Vaccine Market?
Leading organizations in the pertussis vaccine market are focusing on the development of innovative medicines, securing necessary approvals to maintain their market standing. For example, in October 2022, GSK plc, a renowned UK pharmaceutical and biotechnology firm, announced that the U.S Food and Drug Administration (FDA) had approved BOOSTRIX. This vaccine is a blend of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap). It is designed for use during pregnancy to ward off pertussis, commonly known as whooping cough, in newborn babies. Delivered via a single injection into the upper arm muscle, Boostrix has proven safe and effective for expectant mothers and their infants. Moreover, it offers robust protection against pertussis, including its most severe presentations.
Who Are the Key Players In The Pertussis Vaccine Market?
Major companies operating in the pertussis vaccine market are:
• Pfizer Inc.
• Johnson And Johnson Pvt Ltd.
• Merck And Co. Inc.
• Novartis AG
• GlaxoSmithKline PLC
• AstraZeneca PLC
• BioNTech SE
• Moderna Inc.
• Sinovac Biotech Ltd.
• CSL Limited
• Astellas Pharma US Inc.
• Sanofi Pasteur SA
• Mitsubishi Tanabe Pharma America Inc.
• PT Kalbe Farma Tbk
• CSL Seqirus
• Walvax Biotechnology Co.Ltd.
• Biological E. Limited
• Serum Institute of India
• Bavarian Nordic AS
• PT Bio Farma
• Bharat Biotech International Limited
• Takeda Pharmaceutical Company
• Panacea Biotec Limited
• Beijing Minhai Biotechnology Co. Ltd.
• Protein Sciences Corporation
• Wuhan Institute of Biological Products
• Changchun Changsheng Life Sciences
• Changsheng Bio-Technology Co. Ltd.
• Gennova Biopharmaceuticals Ltd.
• Chiron Corporation.
What Is The Most Dominant Region In The Pertussis Vaccine Market?
North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
